JPWO2023069880A5 - - Google Patents
Info
- Publication number
- JPWO2023069880A5 JPWO2023069880A5 JP2024523484A JP2024523484A JPWO2023069880A5 JP WO2023069880 A5 JPWO2023069880 A5 JP WO2023069880A5 JP 2024523484 A JP2024523484 A JP 2024523484A JP 2024523484 A JP2024523484 A JP 2024523484A JP WO2023069880 A5 JPWO2023069880 A5 JP WO2023069880A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- pharmaceutical composition
- medicament
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163262732P | 2021-10-19 | 2021-10-19 | |
| US63/262,732 | 2021-10-19 | ||
| PCT/US2022/078177 WO2023069880A1 (en) | 2021-10-19 | 2022-10-14 | Novel methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539106A JP2024539106A (ja) | 2024-10-28 |
| JP2024539106A5 JP2024539106A5 (https=) | 2025-10-20 |
| JPWO2023069880A5 true JPWO2023069880A5 (https=) | 2025-10-20 |
Family
ID=86058575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523484A Pending JP2024539106A (ja) | 2021-10-19 | 2022-10-14 | 新規方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240415832A1 (https=) |
| EP (1) | EP4419523A4 (https=) |
| JP (1) | JP2024539106A (https=) |
| KR (1) | KR20240089771A (https=) |
| CN (1) | CN118556058A (https=) |
| AU (1) | AU2022368858A1 (https=) |
| CA (1) | CA3235356A1 (https=) |
| IL (1) | IL312165A (https=) |
| MX (1) | MX2024004725A (https=) |
| WO (1) | WO2023069880A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3898580A4 (en) | 2018-12-17 | 2022-08-10 | Intra-Cellular Therapies, Inc. | SYNTHESIS OF CONDENSED GAMMA-CARBOLINES WITH SUBSTITUTED HETEROCYCLE |
| IL283963B2 (en) | 2018-12-17 | 2025-01-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| WO2020132605A1 (en) | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2024194263A1 (en) | 2023-03-17 | 2024-09-26 | Norwegian University Of Life Sciences | Serotonin 5ht2a receptor antagonist for use in treating side effects resulting form mu opioid receptor agonist overdose |
| WO2026011136A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2026011166A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7223742B2 (ja) * | 2017-07-26 | 2023-02-16 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| US20220160704A2 (en) * | 2018-08-08 | 2022-05-26 | Torralva Medical Therapeutics Llc | Compositions for opiate and opioid prevention and reversal, and methods of their use |
| WO2020132605A1 (en) * | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CN118105390A (zh) * | 2019-01-23 | 2024-05-31 | 细胞内治疗公司 | 治疗成瘾的方法 |
| CA3139168A1 (en) * | 2019-05-07 | 2020-11-12 | Nirsum Laboratories, Inc. | Opioid receptor antagonist prodrugs |
| EP4493560A4 (en) * | 2022-03-14 | 2026-03-18 | Intra Cellular Therapies Inc | ORGANIC COMPOUNDS |
-
2022
- 2022-10-14 MX MX2024004725A patent/MX2024004725A/es unknown
- 2022-10-14 KR KR1020247016018A patent/KR20240089771A/ko active Pending
- 2022-10-14 US US18/703,145 patent/US20240415832A1/en active Pending
- 2022-10-14 IL IL312165A patent/IL312165A/en unknown
- 2022-10-14 JP JP2024523484A patent/JP2024539106A/ja active Pending
- 2022-10-14 EP EP22884603.6A patent/EP4419523A4/en active Pending
- 2022-10-14 CA CA3235356A patent/CA3235356A1/en active Pending
- 2022-10-14 WO PCT/US2022/078177 patent/WO2023069880A1/en not_active Ceased
- 2022-10-14 AU AU2022368858A patent/AU2022368858A1/en active Pending
- 2022-10-14 CN CN202280084050.5A patent/CN118556058A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6482838B2 (en) | Methods for treating cognitive impairments caused by traumatic brain injuries | |
| RU2214400C2 (ru) | Производные 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способы их получения, фармацевтическая композиция на их основе и промежуточные вещества | |
| TW202206075A (zh) | 一種藥物組合物及其應用 | |
| JP2019218397A5 (https=) | ||
| JP2013510883A5 (https=) | ||
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| CA2303815A1 (en) | N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain | |
| IL312165A (en) | New methods | |
| RU2008124833A (ru) | Лечение астмы и хронического обструктивного заболевания легких с использованием тройных комбинаций | |
| JP2014526562A (ja) | 疾患の治療方法 | |
| US6740306B2 (en) | Imidazotriazinone-containing compositions for nasal administration | |
| RU2314809C2 (ru) | Способ лечения депрессии соединениями-агонистами дельта-рецепторов | |
| RU2008124838A (ru) | Органические соединения | |
| JPWO2023069880A5 (https=) | ||
| JP2005532397A5 (https=) | ||
| JPH02502185A (ja) | 咳および気管支収縮の治療用５‐ｈｔ３レセプター拮抗物質 | |
| EP4201941A1 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| JPWO2021093839A5 (https=) | ||
| JP2005533038A5 (https=) | ||
| RU2008108175A (ru) | Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы | |
| JP2015180695A (ja) | 静脈におけるウイルスの治療 | |
| US20090163544A1 (en) | Use of NK-3 Receptor Antagonists for the Treatment of Nausea and Vomiting | |
| JP2006516576A5 (https=) | ||
| JP2009538822A5 (https=) | ||
| JP2023525633A (ja) | コロナウイルス感染症の治療のためのスフィンゴシン経路調節化合物 |